AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension

AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension
复制标题

内皮细胞中 AMP 激活的蛋白激酶磷酸化血管紧张素转换酶 2 可减轻肺动脉高压

DOI:
10.1164/rccm.201712-2570oc
复制
发表时间:
2018-08-15
影响因子:
24.7
通讯作者:
Shyy, John Y. -J.
Shyy, John Y. -J.
中科院分区:
医学1区
文献类型:
--
作者:
Zhang, Jiao;Dong, Jianjie;Shyy, John Y. -J.

文献摘要

被引文献

相似文献

原理:内皮功能障碍在肺动脉高压(PH)中起着不可或缺的作用。AMPK(AMP活化蛋白激酶)和ACE 2(血管紧张素转换酶2)在内皮稳态中至关重要。AMPK调节肺内皮中ACE 2的机制及其在PH中的保护作用仍然难以捉摸。目的:我们研究了ACE 2 Ser 680的AMPK磷酸化在ACE 2稳定性中的作用,并破译了ACE 2的这种翻译后修饰在内皮细胞中的功能后果稳态和PH。方法:应用生物信息学预测、激酶活性测定和磷酸化ACE 2 Ser 680抗体(p-ACE 2 S680)研究AMPK磷酸化ACE 2 Ser 680在内皮细胞中的作用。使用CRISPR-Cas9基因组编辑,我们创建了功能获得型ACE 2 S680 D敲入和功能丧失型ACE 2敲除(ACE 22/2)小鼠系,以解决p-ACE 2 S680和ACE 2参与PH的问题。AMPK-p-ACE 2 S680轴也在来自患有特发性肺动脉高压的人的肺组织中得到验证。AMPK对ACE 2的磷酸化增强了ACE 2的稳定性,从而增加了Ang(血管紧张素)1-7和内皮型一氧化氮合酶衍生的NO的生物利用度。与野生型同窝小鼠相比,ACE 2 S680 D基因敲入小鼠对PH具有抗性。相反,ACE 2敲除小鼠加重了PH,这是在AMPK α 2内皮细胞特异性缺失的小鼠中发现的类似表型。结论:AMPK对肺血管内皮细胞ACE 2 Ser 680磷酸化的影响导致ACE 2不稳定,从而导致肺动脉高压的发生,AMPK对ACE 2的调节是肺动脉高压治疗的潜在靶点。
Rationale: Endothelial dysfunction plays an integral role in pulmonary hypertension (PH). AMPK (AMP-activated protein kinase) and ACE2 (angiotensin-converting enzyme 2) are crucial in endothelial homeostasis. The mechanism by which AMPK regulates ACE2 in the pulmonary endothelium and its protective role in PH remain elusive.Objectives: We investigated the role of AMPK phosphorylation of ACE2 Ser680 in ACE2 stability and deciphered the functional consequences of this post-translational modification of ACE2 in endothelial homeostasis and PH.Methods: Bioinformatics prediction, kinase assay, and antibody against phospho-ACE2 Ser680 (p-ACE2 S680) were used to investigate AMPK phosphorylation of ACE2 Ser680 in endothelial cells. Using CRISPR-Cas9 genomic editing, we created gain-of-function ACE2 S680D knock-in and loss-of-function ACE2 knockout (ACE22/2) mouse lines to address the involvement of p-ACE2 S680 and ACE2 in PH. The AMPK-p-ACE2 S680 axis was also validated in lung tissue from humans with idiopathic pulmonary arterial hypertension.Measurements and Main Results: Phosphorylation of ACE2 by AMPK enhanced the stability of ACE2, which increased Ang (angiotensin) 1-7 and endothelial nitric oxide synthase-derived NO bioavailability. ACE2 S680D knock-in mice were resistant to PH as compared with wild-type littermates. In contrast, ACE2-knockout mice exacerbated PH, a similar phenotype found in mice with endothelial cell-specific deletion of AMPK alpha 2. Consistently, the concentrations of phosphorylated AMPK, p-ACE2 S680, and ACE2 were decreased in human lungs with idiopathic pulmonary arterial hypertension.Conclusions: Impaired phosphorylation of ACE2 Ser680 by AMPK in pulmonary endothelium leads to a labile ACE2 and hence is associated with the pathogenesis of PH. Thus, AMPK regulation of the vasoprotective ACE2 is a potential target for PH treatment.